Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
A. Di Domenico, C. P. Pipinikas, R. S. Maire, K. Bräutigam, C. Simillion, M. S. Dettmer, E. Vassella, C. Thirlwell, A. Perren, I. Marinoni
Abstract
Recent data suggest that Pancreatic Neuroendocrine Tumours (PanNETs) originate from - or {beta}-cells of the islets of Langerhans. The majority of PanNETs are non-functional and do not express cell-type specific hormones. We examined whether tumour DNA methylation (DNAme) profiling combined with genomic data could identify cell of origin and reveal pathways involved in PanNET progression. We analysed genome-wide DNAme data of 125 PanNETs and sorted - and {beta}-cells. To confirm cell identity, we investigated ARX and PDX1 expression. Based on epigenetic similarities, PanNETs clustered in -like, {beta}-like and intermediate tumours. The epigenetic similarity to -cells progressively decreased in the intermediate tumours, which presented unclear differentiation. Specific transcription factor methylation and expression varied in the respective /{beta}-tumour groups. Depending on DNAme similarity to /{beta}-cells, PanNETs have different mutational spectra, stage of the disease and prognosis, indicating potential means of PanNET progression.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs)
- ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
- Distinct malignant cell states and myeloid glutamate signaling associated with aggressive pancreatic neuroendocrine tumors
Jeanna M. Qiu, Jae Won Cho, … William L. Hwang·Clinical Cancer ResearchPeer-reviewed·Mar 18, 2026
- Genome analysis and data sharing informs timing of molecular events in pancreatic neuroendocrine tumour
Rene Quevedo, Anna Spreafico, … Trevor J. Pugh·bioRxiv·Jan 23, 2018
- Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
A. M. Carter, N. Kumar, … J. Bibb·bioRxiv·May 25, 2021
- Epigenomic Heterogeneity of Non-Functional Pancreatic Neuroendocrine Tumors Uncovered by Single nucleus and Spatial ATAC Profiling
Dejiang Wang, Xiangjun Di, … Yang Liu·bioRxiv·Sep 11, 2025